Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00444-x)

Schett G, Loza MJ, Palanichamy A, Fitzgerald O, Ritchlin C, Bay-Jensen AC, Nielsen SH, Gao S, Hsia EC, Kollmeier AP, Xu XL, Baribaud F, Sweet K (2022)

Publication Type: Journal article, Erratum

Publication year: 2022

Journal

Rheumatology and Therapy Adis Open Access

DOI: 10.1007/s40744-022-00470-9

Abstract

The original version of the article is updated. • In the Results section of the Abstract, the text ‘rat- adjusted’ should have read ‘rate adjusted’. • In the Key Summary Points box under the heading ‘What did the study ask?’, the text ‘collage’ should have read ‘collagen’. • In the details below Table 1, the text ‘he mean’ should have read ‘the mean’. • In the Methods section under the heading ‘Statistical Methods’ the text ‘C 50 improvement in ACR criteria’ should have read ‘C 50% improvement in ACR criteria’. • In the Results section under the heading ‘Collagen Biomarkers and Baseline Clinical Features in PsA Patients’ the text ‘PSA’ should have read ‘PsA’. • In Table 2, under the PASI column, the value ‘0.13’ should be in italics ‘0.13’. • In Table 2, the ‘Enthesitis’ column heading should read ‘Enthesitis Score’ with a footnote of: Leeds Enthesitis Index 0–6; the ‘Dactylitis Score’ column heading should have a footnote of: Dactylitis Severity Score 0–60.

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Janssen Pharmaceutica NV BE Belgium (BE) University College Dublin (UCD) IE Ireland (IE) University of Rochester (UR) US United States (USA) (US) Nordic Bioscience A/S DK Denmark (DK)

How to cite

APA:

Schett, G., Loza, M.J., Palanichamy, A., Fitzgerald, O., Ritchlin, C., Bay-Jensen, A.-C.,... Sweet, K. (2022). Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00444-x). Rheumatology and Therapy. https://dx.doi.org/10.1007/s40744-022-00470-9

MLA:

Schett, Georg, et al. "Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00444-x)." Rheumatology and Therapy (2022).

BibTeX: Download